As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review ...

Managing blood sugar levels has become increasingly crucial for overall health and well-being in today's fast-paced world.

Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

Sharina Perry traveled a winding road to get to the front of the pack in developing a material that acts like plastic, but ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced that the U.S. Food and Drug Administration (FDA) has accepted an ...

Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...

Agios Pharmaceuticals, Inc. (AGIO), on Wednesday, announced that its supplemental New Drug Application seeking approval for the ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

The Food and Drug Administration issued draft guidance Jan. 6 on marketing submissions and lifecycle management for ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...